Legal & General Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $247M | Sell |
1,349,832
-109,765
| -8% | -$20.2M | 0.06% | 308 |
|
|
2025
Q4 | $257M | Sell |
1,459,597
-133,802
| -8% | -$21.9M | 0.06% | 309 |
|
|
2025
Q3 | $223M | Buy |
1,593,399
+146,583
| +10% | +$19.8M | 0.05% | 340 |
|
|
2025
Q2 | $182M | Buy |
1,446,816
+161,789
| +13% | +$20.2M | 0.05% | 374 |
|
|
2025
Q1 | $176M | Buy |
1,285,027
+55,020
| +4% | +$7.87M | 0.05% | 367 |
|
|
2024
Q4 | $188M | Sell |
1,230,007
-21,946
| -2% | -$3.7M | 0.05% | 363 |
|
|
2024
Q3 | $243M | Sell |
1,251,953
-18,179
| -1% | -$3.8M | 0.06% | 303 |
|
|
2024
Q2 | $294M | Sell |
1,270,132
-37,588
| -3% | -$8.17M | 0.08% | 242 |
|
|
2024
Q1 | $282M | Sell |
1,307,720
-17,376
| -1% | -$4.07M | 0.08% | 262 |
|
|
2023
Q4 | $343M | Sell |
1,325,096
-13,982
| -1% | -$3.43M | 0.11% | 202 |
|
|
2023
Q3 | $344M | Sell |
1,339,078
-30,443
| -2% | -$8.14M | 0.12% | 166 |
|
|
2023
Q2 | $390M | Buy |
1,369,521
+10,974
| +0.8% | +$3.27M | 0.13% | 157 |
|
|
2023
Q1 | $378M | Sell |
1,358,547
-22,112
| -2% | -$6.12M | 0.14% | 155 |
|
|
2022
Q4 | $382M | Sell |
1,380,659
-48,840
| -3% | -$13.8M | 0.15% | 149 |
|
|
2022
Q3 | $382M | Sell |
1,429,499
-26,471
| -2% | -$5.62M | 0.15% | 141 |
|
|
2022
Q2 | $297M | Buy |
1,455,970
+15,609
| +1% | +$3.19M | 0.11% | 214 |
|
|
2022
Q1 | $303M | Buy |
1,440,361
+82,281
| +6% | +$17.9M | 0.09% | 244 |
|
|
2021
Q4 | $326M | Sell |
1,358,080
-48,116
| -3% | -$12.4M | 0.1% | 225 |
|
|
2021
Q3 | $398M | Buy |
1,406,196
+20,504
| +1% | +$6.72M | 0.13% | 172 |
|
|
2021
Q2 | $480M | Buy |
1,385,692
+189,746
| +16% | +$57.5M | 0.16% | 128 |
|
|
2021
Q1 | $335M | Sell |
1,195,946
-34,528
| -3% | -$9.31M | 0.12% | 188 |
|
|
2020
Q4 | $301M | Sell |
1,230,474
-44,714
| -4% | -$11.5M | 0.12% | 191 |
|
|
2020
Q3 | $362M | Sell |
1,275,188
-35,245
| -3% | -$9.83M | 0.16% | 137 |
|
|
2020
Q2 | $351M | Buy |
1,310,433
+49,950
| +4% | +$15M | 0.17% | 133 |
|
|
2020
Q1 | $399M | Buy |
1,260,483
+5,075
| +0.4% | +$1.54M | 0.23% | 88 |
|
|
2019
Q4 | $373M | Buy |
1,255,408
+15,724
| +1% | +$4.36M | 0.18% | 124 |
|
|
2019
Q3 | $289M | Buy |
1,239,684
+17,002
| +1% | +$3.96M | 0.15% | 156 |
|
|
2019
Q2 | $286M | Sell |
1,222,682
-7,884
| -0.6% | -$1.82M | 0.15% | 148 |
|
|
2019
Q1 | $291M | Buy |
1,230,566
+225,455
| +22% | +$71M | 0.17% | 137 |
|
|
2018
Q4 | $302M | Buy |
1,005,111
+55,176
| +6% | +$17.6M | 0.23% | 94 |
|
|
2018
Q3 | $336M | Sell |
949,935
-22,260
| -2% | -$7.66M | 0.24% | 85 |
|
|
2018
Q2 | $282M | Sell |
972,195
-49,251
| -5% | -$13.8M | 0.22% | 98 |
|
|
2018
Q1 | $280M | Sell |
1,021,446
-41,690
| -4% | -$12.9M | 0.21% | 104 |
|
|
2017
Q4 | $339M | Sell |
1,063,136
-26,454
| -2% | -$8.49M | 0.25% | 90 |
|
|
2017
Q3 | $341M | Buy |
1,089,590
+16,871
| +2% | +$5M | 0.26% | 90 |
|
|
2017
Q2 | $291M | Buy |
1,072,719
+27,459
| +3% | +$7.26M | 0.24% | 96 |
|
|
2017
Q1 | $286M | Buy |
1,045,260
+39,220
| +4% | +$11.1M | 0.24% | 92 |
|
|
2016
Q4 | $285M | Buy |
1,006,040
+8,600
| +0.9% | +$2.55M | 0.27% | 81 |
|
|
2016
Q3 | $312M | Buy |
997,440
+4,902
| +0.5% | +$1.45M | 0.32% | 66 |
|
|
2016
Q2 | $240M | Buy |
992,538
+21,957
| +2% | +$5.79M | 0.25% | 90 |
|
|
2016
Q1 | $253M | Buy |
970,581
+13,166
| +1% | +$3.48M | 0.28% | 81 |
|
|
2015
Q4 | $293M | Sell |
957,415
-26,833
| -3% | -$7.71M | 0.33% | 67 |
|
|
2015
Q3 | $287M | Buy |
984,248
+35,383
| +4% | +$11.7M | 0.35% | 64 |
|
|
2015
Q2 | $383M | Buy |
948,865
+11,046
| +1% | +$4.43M | 0.45% | 43 |
|
|
2015
Q1 | $396M | Sell |
937,819
-3,108
| -0.3% | -$1.22M | 0.47% | 44 |
|
|
2014
Q4 | $319M | Sell |
940,927
-30,274
| -3% | -$9.79M | 0.38% | 58 |
|
|
2014
Q3 | $321M | Sell |
971,201
-28,970
| -3% | -$9.55M | 0.39% | 53 |
|
|
2014
Q2 | $315M | Buy |
1,000,171
+5,362
| +0.5% | +$1.61M | 0.37% | 56 |
|
|
2014
Q1 | $304M | Sell |
994,809
-23,693
| -2% | -$7.52M | 0.37% | 58 |
|
|
2013
Q4 | $285M | Sell |
1,018,502
-1,301
| -0.1% | -$337K | 0.34% | 62 |
|
|
2013
Q3 | $246M | Sell |
1,019,803
-2,259
| -0.2% | -$506K | 0.32% | 68 |
|
|
2013
Q2 | $220M | Buy |
+1,022,062
| New | +$218M | 0.3% | 74 |
|
Other funds holding BIIB
VCM
VPM
Legal & General Group's BIIB Position: Q1 2026 in Review
Legal & General Group reduced its Biogen (BIIB) stake by 7.5% in Q1 2026, selling an estimated $20.2M and leaving 1,349,832 shares worth $247M. The position accounts for 0.06% of the portfolio, ranked #308.
Legal & General Group first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $480M in Q2 2021. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Legal & General Group held 1,349,832 shares of Biogen worth $247M as of Q1 2026.
- Legal & General Group sold 109,765 Biogen shares in Q1 2026, an estimated $20.2M.
- Biogen made up 0.06% of Legal & General Group's portfolio in Q1 2026, its #308 holding.
- Legal & General Group first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
- Legal & General Group's Biogen position peaked at $480M in Q2 2021.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.